The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126446963 12644696 3 F 20160720 20160914 20160811 20160921 EXP FR-ASTELLAS-2016US030531 ASTELLAS 18.60 YR F Y 0.00000 20160921 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126446963 12644696 1 PS PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 Oral 2 MG, TWICE DAILY (2 DF TWICE DAILY) Y N 50708 2 MG FORMULATION UNKNOWN BID
126446963 12644696 2 I PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 Unknown 2 MG, TWICE DAILY (MORNING AND EVENING) U N 50708 2 MG FORMULATION UNKNOWN BID
126446963 12644696 3 I KALETRA LOPINAVIRRITONAVIR 1 Oral 2 DF (STRENGTH: 200 MG/ 50 MG), TWICE DAILY Y 0 2 DF FORMULATION UNKNOWN BID
126446963 12644696 4 SS CEFTRIAXONE. CEFTRIAXONE 1 Unknown 500 MG, TOTAL DOSE (ONE INTAKE) D 0 500 MG FORMULATION UNKNOWN
126446963 12644696 5 SS ZITHROMAX AZITHROMYCIN DIHYDRATE 1 Oral 1000 MG, TOTAL DOSE (4 DF IN ONE INTAKE) D 0 1000 MG FORMULATION UNKNOWN
126446963 12644696 6 SS TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral Y 0 1 DF FORMULATION UNKNOWN QD
126446963 12644696 7 C ORAP PIMOZIDE 1 Unknown D U 0 1 MG FORMULATION UNKNOWN QD
126446963 12644696 8 C PRAVASTATIN. PRAVASTATIN 1 Unknown D U 0 5 MG FORMULATION UNKNOWN QD
126446963 12644696 9 C DESOGESTREL DESOGESTREL 1 Unknown D U 0 1 DF TABLET QD
126446963 12644696 10 C ELLAONE ULIPRISTAL ACETATE 1 Unknown 1 SINGLE DOSE, UNKNOWN FREQUENCY D U 0 FORMULATION UNKNOWN
126446963 12644696 11 C XANAX ALPRAZOLAM 1 Unknown 0.25 MG, AS NEEDED D U 0 .25 MG FORMULATION UNKNOWN
126446963 12644696 12 C VENTOLINE /00139501/ ALBUTEROL 1 Unknown UNK UNK, AS NEEDED D U 0 FORMULATION UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126446963 12644696 1 Heart transplant
126446963 12644696 3 Prophylaxis against HIV infection
126446963 12644696 4 Product used for unknown indication
126446963 12644696 5 Prophylaxis urinary tract infection
126446963 12644696 6 Prophylaxis against HIV infection
126446963 12644696 7 Product used for unknown indication
126446963 12644696 8 Product used for unknown indication
126446963 12644696 9 Product used for unknown indication
126446963 12644696 10 Product used for unknown indication
126446963 12644696 11 Anxiety
126446963 12644696 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126446963 12644696 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126446963 12644696 Anxiety
126446963 12644696 Drug interaction
126446963 12644696 Immunosuppressant drug level increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126446963 12644696 1 20160718 0
126446963 12644696 2 20160723 0
126446963 12644696 3 20160716 20160720 0
126446963 12644696 4 20160716 20160716 0
126446963 12644696 5 20160716 20160716 0
126446963 12644696 6 20160716 20160720 0
126446963 12644696 10 20160716 0